Joly, R., Tasnim, F., Krutsinger, K., Li, Z., Pullen, N., Han, Y. (2025). Cannabigerol Alleviates Liver Damage in Metabolic Dysfunction-Associated Steatohepatitis Female Mice via Inhibition of Transforming Growth Factor Beta 1. Nutrients.
Aljobaily, N., Krutsinger, K., Viereckl, M., Joly, R., Menlove, B., Cone, B., Suppes, A., Han, Y. (2023). Low dose administration of Cannabigerol attenuates inflam-mation and fibrosis associated with methionine/choline deficient diet-induced NASH model via modulation of cannabinoid receptor. Nutrients.
Viereckl MJ, Krutsinger K, Apawu A, Gu J, Cardona B, Barratt D, Han Y. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules. 2022 Jun 20;12(6):854. doi: 10.3390/biom12060854. PMID: 35740979; PMCID: PMC9221388.
Aljobaily, N., Viereckl, M., Hydock, D., Aljobaily, H., Wu, T.-Y., Busekrus, R., Jones, B., Alberson, J., Han, Y. (2020). Creatine Alleviates Doxorubicin Induced Liver Damage by Inhibiting Cellular Senescence, Oxidative-Induced Inflammation and Liver Fibrosis.. DOI: 10.3390/nu13010041
Han Y, Junfeng Xu, Jeri Kim, Xifeng Wu, Jian Gu; Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients, Carcinogenesis. 2017 Aug; 38 (8) : 821–826, doi: 10.1093/carcin/bgx064. PMID: 28854562
Han Y, Meng F, Venter J, Wu N, Wan Y, Standeford H, Francis H, Meininger C, Greene J Jr, Trzeciakowski JP, Ehrlich L, Glaser S, Alpini G. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth. J Hepatol. 2016 Jun;64(6):1295-304. doi: 10.1016/j.jhep.2016.02.024. Epub 2016 Feb 24. PMID: 26923637